In today’s recent session, 0.4 million shares of the ProPhase Labs Inc (NASDAQ:PRPH) have been traded, and its beta is -0.30. Most recently the company’s share price was $0.78, and it changed around $0.06 or 8.83% from the last close, which brings the market valuation of the company to $18.70M. PRPH at last check was trading at a discount to its 52-week high of $7.48, offering almost -858.97% off that amount. The share price’s 52-week low was $0.61, which indicates that the recent value has risen by an impressive 21.79% since then. We note from ProPhase Labs Inc’s average daily trading volume that its 10-day average is 0.18 million shares, with the 3-month average coming to 186.84K.
ProPhase Labs Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended PRPH as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. ProPhase Labs Inc is expected to report earnings per share of -0.24 for the current quarter.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Instantly PRPH has been showing a green trend so far today with a performance of 8.83% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.8638 on recent trading dayincreased the stock’s daily price by 9.7%. The company’s shares are currently down -82.68% year-to-date, but still up 23.58% over the last five days. On the other hand, ProPhase Labs Inc (NASDAQ:PRPH) is 1.44% up in the 30-day period. We can see from the shorts that 0.15 million shares have been sold at a short interest cover period of 7.04 day(s).
The consensus price target as assigned by Wall Street analysts is $14, which translates to bulls needing to increase their stock price by 94.43% from its current value. Analyst projections state that PRPH is forecast to be at a low of $14 and a high of $14.
ProPhase Labs Inc (PRPH) estimates and forecasts
ProPhase Labs Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -79.39 percent over the past six months and at a -25.51% annual growth rate that is well below the industry average of 16.60%. The year-over-year growth rate is expected to be -67.29%, down from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 5.88M in revenue for the current quarter. 1 analysts expect ProPhase Labs Inc to make 5.64M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 4.35M and 3.63M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 35.14%. Forecasts for the next quarter put sales growth at 55.20%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -47.90%.
PRPH Dividends
ProPhase Labs Inc’s next quarterly earnings report is expected to be released in January.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.34% of ProPhase Labs Inc shares, and 7.63% of them are in the hands of institutional investors. The stock currently has a share float of 8.91%. ProPhase Labs Inc stock is held by 39.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.6351% of the shares, which is about 0.66 million shares worth $2.74 million.
RENAISSANCE TECHNOLOGIES LLC, with 1.222% or 0.22 million shares worth $0.92 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 454.64 shares worth $0.36 million, making up 1.90% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 181.39 shares worth around $0.14 million, which represents about 0.76% of the total shares outstanding.
